Market open
Stevanato Group/$STVN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stevanato Group
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Ticker
$STVN
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Piombino Dese, Italy
Employees
5,521
ISIN
IT0005452658
Website
Stevanato Group Metrics
BasicAdvanced
$6.4B
45.30
$0.51
0.51
$0.05
0.23%
Price and volume
Market cap
$6.4B
Beta
0.51
52-week high
$24.96
52-week low
$16.56
Average daily volume
364K
Dividend rate
$0.05
Financial strength
Current ratio
1.825
Quick ratio
1.249
Long term debt to equity
22.143
Total debt to equity
27.989
Dividend payout ratio (TTM)
11.52%
Interest coverage (TTM)
27.00%
Management effectiveness
Return on assets (TTM)
4.88%
Return on equity (TTM)
9.14%
Valuation
Price to earnings (TTM)
45.302
Price to revenue (TTM)
5.046
Price to book
4.49
Price to tangible book (TTM)
4.77
Price to free cash flow (TTM)
-57.538
Dividend yield (TTM)
0.23%
Forward dividend yield
0.23%
Growth
Revenue change (TTM)
3.81%
Earnings per share change (TTM)
-9.91%
3-year revenue growth (CAGR)
9.22%
3-year earnings per share growth (CAGR)
-1.51%
What the Analysts think about Stevanato Group
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Stevanato Group stock.
Stevanato Group Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Stevanato Group Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Stevanato Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market open
Upcoming events
Jun5
Stevanato Group
Dividend·Ex-dividend
Jul17
Stevanato Group
Dividend·Payment
€0.054Per share
FAQs
What’s the current market cap for Stevanato Group stock?
Stevanato Group (STVN) has a market cap of $6.4B as of May 16, 2025.
What is the P/E ratio for Stevanato Group stock?
The price to earnings (P/E) ratio for Stevanato Group (STVN) stock is 45.3 as of May 16, 2025.
Does Stevanato Group stock pay dividends?
Yes, the Stevanato Group (STVN) stock pays dividends to shareholders. As of May 16, 2025, the dividend rate is $0.053 and the yield is 0.23%. Stevanato Group has a payout ratio of 11.52% on a trailing twelve-month basis.
When is the next Stevanato Group dividend payment date?
The next Stevanato Group (STVN) dividend payment is scheduled for July 17, 2025.
What is the beta indicator for Stevanato Group?
Stevanato Group (STVN) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.